Safety-Directed Drug Design: Failures can be successes

The failure of a drug or clinical candidate is invariably associated with a massive amount of basic science that goes into problem-solving activities. Thus, a more rational approach to safety assessments in early drug discovery is presently the focus of large centrally funded predictive toxicology initiatives both in Europe and the US. Read the condensed version of the full article published in Medicinal Chemistry in Europe, the Yearbook of EFMC

By Scott Boyer

Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen

In this issue Professor Povl Krogsgaard-Larsen and the Department of Medicinal Chemistry, The Faulty of Pharmaceutical Sciences at the University of Copenhagen are introduced.

By Kristian Strømgaard and Rasmus P. Clausen

Frontiers in CNS and Oncology Medicinal Chemistry

EFMC meetings features the first joint ACS-EFMC meeting held in Siena, Italy, Oct. 7-9. You will also find a short overview on the EFMC sponsored session at the Fall ACS Meeting, Boston, Aug. 19.

By Roberto Pellicciari & Gerhard Ecker

Call for Nominations open till Jan 31, 2008

The EFMC confers every two years, on the occasion of the EFMC-ISMC Symposium, three awards including the Nauta Award for Pharmacochemistry, the UCB-Ehrlich Award for Excellence in Medicinal Chemistry, and the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery.

By Gerhard Ecker